UBS Q2 Review on MDC Partners (MDCA): Better Revenues Offset by Expenses; Guidance Unchanged
Tweet
Share
E-mailGet Alerts MDCA Hot Sheet
Price: $5.42 --0%
Rating Summary:
7 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
7 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS maintains a 'Buy' on MDC Partners (NASDAQ: MDCA) price target of $15.00.
Analyst, John Janedis, reviewing the company's Q2 results, said better revenues were offset by expenses. 2012 guidance is unchanged. (the company reported a Q2 loss)
For FY12, MDCA sees revenues between $1.05-1.075 billion vs. consensus estimate of $1.07 billion.
For an analyst ratings summary and ratings history on MDC Partners click here. For more ratings news on MDC Partners click here.
Shares of MDC Partners closed at $9.48 yesterday.
Analyst, John Janedis, reviewing the company's Q2 results, said better revenues were offset by expenses. 2012 guidance is unchanged. (the company reported a Q2 loss)
For FY12, MDCA sees revenues between $1.05-1.075 billion vs. consensus estimate of $1.07 billion.
For an analyst ratings summary and ratings history on MDC Partners click here. For more ratings news on MDC Partners click here.
Shares of MDC Partners closed at $9.48 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Wolverine World Wide (WWW) PT Raised to $31 at UBS on Growth, EPS Upside Potential
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
